Viewing Study NCT01674595


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-26 @ 10:06 PM
Study NCT ID: NCT01674595
Status: COMPLETED
Last Update Posted: 2013-04-30
First Post: 2012-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy
Sponsor: ALK-Abelló A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AV-X-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators